QMNRX
Price
$11.78
Change
+$0.07 (+0.60%)
Updated
Jun 22 closing price
Net Assets
2.95B
VMNFX
Price
$15.98
Change
+$0.19 (+1.20%)
Updated
Jun 22 closing price
Net Assets
561.94M
Interact to see
Advertisement

QMNRX vs VMNFX

QMNRX vs VMNFX Comparison Chart in %
View a ticker or compare two or three
VS
QMNRX vs. VMNFX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QMNRX is a Hold and VMNFX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
QMNRX has more cash in the bank: 2.95B vs. VMNFX (562M). VMNFX pays higher dividends than QMNRX: VMNFX (3.17) vs QMNRX (1.56). QMNRX was incepted earlier than VMNFX: QMNRX (12 years) vs VMNFX (28 years). QMNRX (5.91) is less costly to investors than VMNFX (1.95). QMNRX is a more actively managed with annual turnover of: 338.00 vs. VMNFX (108.00). VMNFX has a lower initial minimum investment than QMNRX: VMNFX (50000) vs QMNRX (50000000). VMNFX annual gain was more profitable for investors over the last year : 19.30 vs. QMNRX (4.21). QMNRX return over 5 years is better than : 135.35 vs. VMNFX (81.56).
QMNRXVMNFXQMNRX / VMNFX
Total Expense Ratio5.911.95303%
Annual Report Gross Expense Ratio5.911.95303%
Fund Existence12 years28 years-
Gain YTD-6.28513.004-48%
Front LoadN/AN/A-
Min. Initial Investment5000000050000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.95B562M525%
Annual Yield % from dividends1.563.1749%
Returns for 1 year4.2119.3022%
Returns for 3 years66.7040.36165%
Returns for 5 years135.3581.56166%
Returns for 10 years49.3647.25104%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JIEMX15.31N/A
N/A
JHancock Equity Income 1
SGICX17.67N/A
N/A
SGI US Large Cap Equity C
TAGRX66.05N/A
N/A
JHancock Fundamental Large Cap Core A
TMDIX17.80N/A
N/A
AMG TimesSquare Mid Cap Growth Z
EEMEX12.84N/A
N/A
MFS Emerging Markets Equity Research R2